| NAME |
CLONIDINE 0.04MG/KETOROLAC 15MG/ROPIVACAINE 123MG/50ML INJ SYRIN |
| VA GENERIC NAME |
CLONIDINE/KETOROLAC/ROPIVACAINE |
| DOSAGE FORM |
INJ |
| HAZARDOUS TO DISPOSE |
NO |
| ACTIVE INGREDIENTS |
|
| CS FEDERAL SCHEDULE |
Unscheduled |
| SINGLE/MULTI SOURCE PRODUCT |
Multisource |
| NATIONAL FORMULARY NAME |
CLONIDINE/KETOROLAC/ROPIVACAINE INJ |
| CREATE DEFAULT POSSIBLE DOSAGE |
NO |
| POSSIBLE DOSAGES TO CREATE |
No Possible Dosages |
| CODING SYSTEM |
|
| COPAY TIER |
-
- COPAY TIER LEVEL: 2
- COPAY EFFECTIVE DATE: 2022-04-06 00:00:00
|
| PGX ELIGIBLE |
NO |
| PGX SUPPRESSED |
NO |
| VA PRINT NAME |
CLONIDI 0.04/KETOR 15/ROPIVAC 123MG/50ML |
| VA PRODUCT IDENTIFIER |
C2032 |
| TRANSMIT TO CMOP |
NO |
| VA DISPENSE UNIT |
SYR |
| MASTER ENTRY FOR VUID |
YES |
| VUID |
4041309 |
| EFFECTIVE DATE/TIME |
-
- 2022-04-06 00:00:00
- STATUS: ACTIVE
|